Caregen
케어젠 · 214370
Health Care Pharmaceuticals · KOSDAQ
Market cap US$3.2B (₩4.4T)
Overview
Caregen develops and supplies peptide-based ingredients and formulations used in cosmetics and hair-care products, as well as pharmaceutical and medical-aesthetic applications.
Its customers include cosmetic brands, clinics, and other companies that incorporate its active ingredients into their own finished products. Listed on KOSDAQ, South Korea's technology and small-cap exchange, the company conducts its own research and development as a core part of its business model.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue · FY2025
US$52.8M
▼ −11.8% YoY
Operating profit · FY2025
US$14.8M
▼ −40.4% YoY
Net income · FY2025
US$14.6M
▼ −37.8% YoY
Revenue
- FY2023US$57.4M
- FY2024US$59.8M
- FY2025US$52.8M
Operating profit
- FY2023US$29.3M
- FY2024US$24.8M
- FY2025US$14.8M
Net income
- FY2023US$28.9M
- FY2024US$23.4M
- FY2025US$14.6M
Key ratios (FY2025)
ROE
9.5%
Debt/Eq
8.8%
Op. margin
28.0%
Net margin
27.6%
Rev. YoY
▼ −11.8%
Price charts coming soon
Interactive price history isn't here yet. Would you use it?